Merck & Co Makes Case For Molnupiravir After Narrow FDA Nod

Backing Comes Day After Pfizer's Paxlovid Green Light

 
• By M. Nielsen Hobbs
  
Merck_New_Jersey
• Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip